Recce Pharmaceuticals Ltd
ASX:RCE

Watchlist Manager
Recce Pharmaceuticals Ltd Logo
Recce Pharmaceuticals Ltd
ASX:RCE
Watchlist
Price: 0.455 AUD -5.21% Market Closed
Market Cap: 105.5m AUD
Have any thoughts about
Recce Pharmaceuticals Ltd?
Write Note

Wall Street
Price Targets

RCE Price Targets Summary
Recce Pharmaceuticals Ltd

There are no price targets for RCE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Recce Pharmaceuticals Ltd Competitors:
Price Targets
SDZ
Sandoz Group AG
14% Upside
002262
Jiangsu Nhwa Pharmaceutical Co Ltd
33% Upside
TARS
Tarsus Pharmaceuticals Inc
24% Upside
039200
Oscotec Inc
74% Upside
600521
Zhejiang Huahai Pharmaceutical Co Ltd
9% Upside
1795
Lotus Pharmaceutical Co Ltd
72% Upside
TORNTPHARM
Torrent Pharmaceuticals Ltd
4% Upside

Revenue
Forecast

Revenue Estimate
Recce Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for Recce Pharmaceuticals Ltd's revenue is 53%. The projected CAGR for the next 2 years is 12%.

53%
Past Growth
12%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Recce Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Recce Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RCE's stock price target?
Not Available

RCE doesn't have any price targets made by Wall Street professionals.

What is Recce Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Recce Pharmaceuticals Ltd's revenue is 53%. The projected CAGR for the next 2 years is 12%.

Back to Top